Stock & Company Details
Acumen Pharmaceuticals Inc $ABOS
Price:
N/A
N/A
72M
$219M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.57
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABOS technical indicators
Latest Acumen Pharmaceuticals Inc (ABOS) indicator readings as of 2026-08-28.
ABOS's 14-day RSI is 60.3, in neutral territory. At $2.92 it is trading 21.0% above its 200-day moving average of $2.41, and above its 50-day average of $2.51. Price sits in the middle of its Bollinger Bands ($2.02 to $3.38). ADX reads 38.4, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believe to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
Finance Bot
Ask your questions
Start by typing a question below.
